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Abstract 
 
Clinical pathway is a management tool utilized in hospitals in order to reduce variation in medical care as well as control 
health quality. Poor adherence to the clinical pathway documents most probably leads to deficiency in quality of care. This 
paper presents the result of an investigation for the role of clinical pathway document component (design) on the use of the 
clinical pathway tool in practice. We checked the content of three clinical pathway designs using the Integrated Care 
Pathway Appraisal Tool (ICPAT). Negative correlation between the compliance to ICPAT indicators and the completeness of 
third clinical pathway design has been obtained. Standard criteria in designing clinical pathway shows discrepancy which 
might be due to reluctances among the users to follow the lengthy procedure. In conclusion, user’s preferences need to be 
considered for more practical use of clinical pathway beside the standard documentation perfection in order to achieve its 
objectives.  
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Abstrak 
 
laluan klinikal merupakan alat pengurusan yang digunakan di hospital-hospital bertujuan mengurangkan kepelbagaian 
dalam rawatan perubatan serta mengawal kualiti kesihatan. Pematuhan yang lemah terhadap dokumen-dokumen laluan 
klinikal akan mengurangkan kualiti kesihatan. Kertas kerja ini membentangkan hasil penyelidikan ke atas peranan komponen 
(rekabentuk) dokumen aliran klinikal dan mengenai kegunaan dokumen aliran klinikal dalam pelaksanaan. Pemeriksaan isi 
kandungan rekabentuk aliran klinikal menggunakan Alat Penilaian Penjagaan Bersepadu (ICPAT). Hubungkait yang negatif 
di antara penyesuaian indikator ICPAT dan kesempurnaan rekabentuk aliran klinikal diperolehi. Kriteria yang ditetapkan 
dalam merekabentuk aliran klinikal menunjukkan percanggahan mungkin diakibatkan oleh keengganan para pengguna 
untuk mengikuti prosedur yang panjang. Kesimpulannya, pilihan pengguna perlu dipertimbangkan untuk kegunaan aliran 
klinikal yang lebih praktikal di samping kesempurnaan dokumentasi piawai dalam mencapai objektif. 
 
Kata kunci: Laluan klinikal STEMI, petunjuk kualiti, pematuhan standard 
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1.0  INTRODUCTION 
 
A Clinical pathway (CP) has been used as a 
management tool to standardize the care process, 
improve time to care access and improve health 
care quality [1]. Furthermore, European Pathway 
Association (2011)[2], defines the clinical pathway as: 
‘an intervention plan for the mutual decision making 
and organization of care processes for a well-defined 
group of patients during a well-defined period’. 
During the past 30 years, much more information has 
been available on the clinical pathway 
development and implementation [3]–[5]. Since the 
adoption of the operational methodology from 
industries to health care, it has been prooved 
effective and efficient in tackling the cost and time 
management. What we know about clinical 
pathway is largely based on pre and post 
implementations evaluative studies that investigate 
the impact of clinical pathway on cost and quality.  
On the other hand, interestingly, quality as an 
important endpoint to clinical pathway still not 
clearly identified and defined. It has been tackled in 
many research as  an outcome efficacy of the used 
document. However, what is not yet clear is the 
impact of clinical pathway design on the 
completeness of the document, and its effect on 
quality. 
 
 
2.0  RELATED STUDIES 
 
A key aspect of medical care is the quality of service 
and its outcome. In health service, one of the less 
tackled points in quality is the design. For  better 
care, we need to emphasize on the design and its 
effect on improving the car [6]–[8] . Quality has been 
undertaken as ‘the end measurement of the process 
and activities that have been deployed during the 
patient treatment in hospital. The outcome such as 
mortality has been mostly undertaken as the 
endpoint measure for the quality despite the 
importance of the structure as an important indicator 
for medical care quality[9]–[12].  That might be due 
to what have been pointed out by Dondbedian 
(2005), as he mentioned that “ there is still an unclear 
relation between the structure with the other two 
quality indicators process and outcome”.  
Clinical pathway as an operational management 
tool  has a unique characteristic. Rather than what 
traditionaly have been viewed, the component of 
the structure just  the adequacy of equipment’s, 
human resource the operation of the program etc, 
there are some other less praised charectristics. For 
example, the effect of development component 
with considering the dynamic nature of the process 
of care which could lead to variation in practice.  
Besides that, an important characteristic is ‘the 
professional users’. They have their opinion, which 
may be opposing to the use of the clinical pathway. 
Consequently, the Use of  clinical pathway could be 
considered by the professionals as “cookbook” that 
limits their decisions freedom [13]. Although, some 
studies have been carried out on the development 
of clinical pathway, there have been few empirical 
investigations into the design and evaluating its 
quality [14]–[17].   
Some studies failed to specify whether they follow 
the standard in clinical pathway development other 
than guidelines. Furthermore, not clear what are the 
tools they use in clinical pathway development, and 
whether it has improved the quality of care or not. 
While, much of the current literature on quality of 
care pays particular attention to the process and 
outcome measures [18], the design measure not 
mentioned in most of the studies [19]–[23].  
Patients on clinical pathway have a shorter 
average length of stay and a lower rate of 
complications compared to patients, not on the 
clinical pathway [22]–[24]. However, evidence shows 
that there are variation in the use of health services 
for conditions and circumstances that are quite 
similar. These variations could be a result of some 
influencing factors that have been explored in 
several studies, and has been  found to have effect 
on quality of medical care [14], [25]–[27]. While most 
of the affecting factors are related to patients, 
organization, and clinical pathway development.   
The effect of clinical pathway design on the quality 
of care have been out of sight. There has been little 
agreement on what is the exact definition and 
standard for development of clinical pathway for 
along time . Although, the aspects for compliance to 
treatment process or clinical care after using clinical 
pathway documents implimentation have been the 
focus of several studies [28]–[31]. Thus far, there are a 
few studies have engage in the document 
component and design as an indicator for quality 
care [9], [30], [32], etc. In auditing, completeness of 
records might be used as an indicator for quality 
improvement.   
According to Nicholson (2013), the idea of 
complete and accurate patient record 
documentation has come to advance the quality 
and continuity of care. Similarly, it builds a mean of 
exchange between providers and between 
providers and members about health status, 
preventive health services, treatment, planning, and 
delivery of care [33]. It represent the compliance to 
the standard that oftenly used in health care to 
promote quality improvements, i.e. to achieve 
changes in organizational structures or processes, 
health care provider behavior and patient 
outcomes.  
It is not clear what is the impact of clinical pathway 
design on the completeness of the document, and 
its effect on quality. The success of the 
implementation of the clinical pathway could be 
known from the completeness of document ‘medical 
record’. From literature study conducted in this study, 
it is observed that , the tools that discuss design 
factor are scanty in relation to the prevalence of 
clinical pathway use.   
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One of the a ppraised tool to analyze the design of 
clinical pathway has dragged our attention 
‘Integrated Care Pathway Appraisal Tool’ (ICPAT) as 
the most appropriate audit tool to assess clinical 
pathway documents by [8], [16]. Also, it consists of 
section that condsider the design of clinical pathway 
document, that was a very important inclusion 
criteria for this study. Therefore, it have been selected 
to be used in evaluation of clinical pathway 
compliance to its indicators. The component of 
clinical pathway thought to be the optimal care that 
required for better medical care outcome. Therefore, 
deviation from the clinical pathway will lead to low 
quality. In this paper, we argue that the design of the 
clinical pathway document has a role in the usability 
of its components and ultimately that would be an 
important factor in the quality of medical care [9]. 
The main objective of this study is to determine the 
correlation between design and completeness of the 
document. To investigate whether the documents 
that follow standard will has more usability or not. In 
the following sections, the method and results for 
analysis of three clinical pathway designs and the 
completeness of the clinical pathway retrospective 
documents will be described. It will finally go on to 
the discussion and conclusion.  
 
 
3.0  METHODOLOGY 
 
In In this study, we adopted the descriptive case 
study design. We used two sources of evidence: 
documents (three clinical pathway documents with 
different design Clinical pathway 1 (CP1), clinical 
pathway 2 (CP2) and Clinical Pathway 3 (CP3) for 
the same disease and retrospective filled clinical 
pathway documents). The data collected from a 
tertiary hospital which based on some inclusion 
criteria. The hospital should be a referring hospital for 
STEMI patients with at least one trial in the clinical 
pathway. Generally, this research was conducted in 
two phases. In the first phase, we conducted a 
literature review to identify the studies that have 
discussed the design of the clinical pathway in its 
scope. After that, only one that mainly discusses the 
design was used in benchmarking the design of CPs 
and the tool indicators has been used as standard 
variables for this study. We have explored the context 
and described the clinical pathway in real settings.   
Prior to commencing the study, ethical clearance 
was sought from the ethics board. The mutual 
agreement to access the data was reached based 
on a memorandum of agreement between the 
hospitals and the research group. In the second 
phase, a retrospective analysis was performed to 
investigate the completeness of 297 filled clinical 
pathway documents. Due to the time constraint and 
the cost that could affect this study, it was difficult to 
do a prospective randomized study. Therefore, the 
sample was collected from an eligible collaborated 
hospital. In this study, the population of interest was 
the ST-Elevation Myocardial Infarction (STEMI) clinical 
pathway design. Three designs from a hospital were 
collected. Statistical analysis was performed using 
SPSS software (version 22). The final explanation of 
the significance of the finding follows the descriptive 
nature. Statistical significance was analyzed using 
Spearman correlation tests as appropriate. Ranking 
for the best design was done and critical description 
of the factors underlies the preference is explained 
within the context of the discussion section. 
 
 
4.0  RESULTS AND DISCUSSION 
 
4.1 Compliance to ICPAT 
 
As a result of a literature search for the available tools 
or standard to evaluate the design of the clinical 
pathway document, we found the Integrated Care 
Pathway Appraisal Tools (ICPAT) [8], [16] which has 
been developed within the West Midlands region of 
the UK assessing the quality of the integrated clinical 
pathway (ICPs).It has been considered as one of the 
few available tools that check the design of CP. It 
gives a standard for the design of any clinical 
pathway. The researchers have analyzed the clinical 
pathway compliance to the checklist tool indicators. 
The optimal design is defined in our study as ‘the 
design or model of the clinical pathway that have 
the majority of the Integrated Care Pathway 
Appraisal Tools (ICPAT) tool component’. ICPAT have 
been considered as a valid tool to assess the design 
of the clinical pathway in several researches 
regardless of its focus on the document structure. We 
have only chosen the tool that has some focus on 
the documentation as an important eligibility 
criterion to include this tool in our study. We follow the 
evidence in the literature [8], [16] to justify our 
selection. The first set of analyses compared the 
indicators in the ICPAT checklist to the three STEMI 
clinical pathway designs. 
 
Table1 Standard design documentation indicators in ICPAT 
tool 
 
No Element 
1 Front page 
2 Abbreviation section 
3 Reference section 
4 Version control 
5 Clearly defined patient group and scope 
6 A plan of expected/anticipated care along some 
form of timeline 
7 Sequential order 
8 Documentation from all the discipline involve 
9 Evidenced-based practiced and guidelines 
10 Included process and outcome 
11 Variances-recording framework 
12 Risk management tools 
13 Place the patient at the center of the care cycle 
14 Facilitate and promote continuous quality 
improvement 
Adapted from de Luc & Whittle (2002) ICPAT [8] 
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The indicators of benchmarking tool are shown in 
Table 1. It shows the fourteen indicators of the 
Checklist of the Integrated Care Pathway Appraisal 
Tools (ICPAT) that was used to benchmark the design 
of the three clinical pathways.  
 
Table 2 Clinical Pathway Compliance to Checklist 
 
Clinical Pathways version (CP)1 
 
Frequency Percent 
Cumulative 
Percent 
Valid 
Yes 9 64.3 64.3 
No 5 35.7 100.0 
Clinical Pathways version(CP) 2 
 
Frequency Percent 
Cumulative 
Percent 
Valid 
Yes 9 64.3 64.3 
No 5 35.7 100.0 
Clinical Pathways version(CP) 3 
 
Frequency Percent 
Cumulative 
Percent 
Valid 
Yes 10 71.4 71.4 
No 4 28.6 100.0 
 
 
As shown in Table 2 the frequency of hits was 
calculated for each clinical pathway version. The 
percentage of completeness was similar in clinical 
pathway 1 and 2 with 64.3% while it was 71.4% for 
clinical pathway 3. All the 3 pathways stated patient 
group and they differ in arranging the activities. Even 
though, both Clinical pathway 1 and Clinical 
pathway 2 were equals in term of compliance to the 
ICPAT standard indicators, there were differences in 
the arrangements of activities and details of process 
components. From Figure 1 it can be seen that all the 
three clinical pathway models have no front page, 
abbreviation section, reference section and version 
control, while Clinical pathway 3 was the only model 
that includes the (documentation from all the 
discipline involve) indicator.  The frequency of using 
the checklist indicators and compatibility with ICPAT 
was calculated. We found that Clinical pathway 3 
was the most compliance version to ICPAT standard 
with the percentage of 71.4 as shown in Figure 2. 
 
 
 
Figure 1 Compliance of Different Clinical pathway 
Documents Designs with ICPAT Tool Indicators. Note: 2= 
have,1=do not have, CP1= clinical pathway design number 
one, CP2= clinical pathway design number two, CP3= 
clinical pathway design number three 
 
 
4.2  Clinical Pathway Designs Completeness 
 
Initially, 500 documents collected for a clinical 
pathway for STEMI (ST-Elevation Myocardial 
Infarction) patients. However, only 294 documents 
were valid from the three STEMI clinical pathways 
designs, the rest were excluded to avoid the bias in 
the comparison. We excluded the documents that 
have been un-readable, not STEMI or not used at all.  
The data were collected from the hospital records 
for the year 2012 until the year 2014 for both STEMI 
patients’ genders, male and female and for 18 years 
and above. The frequency of completeness of the 
three Clinical Pathway shows that the Clinical 
Pathway 1 has the most usage among the other 
designs. As noticed from the analysis of retrospective 
CPs documents clinical pathway 3 had the lowest 
percentage of documents completeness with only 
18.4%, regardless its highest compliance to the ICPAT 
standard while, Cp1 owned the highest value of 
completeness with 46.9%.  These results show that 
compliance to the clinical path standard (ICPAT) 
had a negative influence on the documents 
completeness. 
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Figure 2 Clinical pathway completeness by user’s versus 
compliance to the standard. Note: CP1= clinical pathway 
design number one, CP2= clinical pathway design number 
two, CP3= clinical pathway design number three 
 
 
Although; CP1 and Cp2 had the same value of 
compliance to standards they differ in term of 
completeness which indicate that there are other 
factors might affect this measure. The estimations of 
clinical pathway completeness according to the 
discrepancy above are shown in the Figure 2. Mostly, 
in all designs the statistics show no significant 
deviation from the mean and that most probably 
due to using the data from the same source and 
setting for the same type of disease as shown in Table 
3. 
 
Table 3 Clinical Pathway Completeness Description  
 
statistics N Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
Clinical 
pathway design 
294 1.7143 .75722 .04416 
 
 
4.3  Correlation Analysis  
 
By using the medians for the two aforementioned 
analyses and doing Spearman correlation test we 
tried to find the correlation between the clinical 
pathway design and its completeness. Descriptive 
analysis has been conducted through CP1, CP2 and 
CP3 as shown in Table 4. 
 
Table 4 Descriptive Statistics for Clinical Pathway 
compliance to ICPAT Components in three designs 
 
 
Clinical 
Pathways 
version 1 
Clinical 
Pathways 
version 2 
Clinical 
Pathways 
version 3 
N 
Valid 14 14 14 
Missing 0 0 0 
Mean 1.3571 1.3571 1.2857 
Std. Error of 
Mean 
.13289 .13289 .12529 
Std. Deviation .49725 .49725 .46881 
As presented in Table 5, the significance of the 
association between the completion of three clinical 
pathway designs (CPd) and the compliance to 
standard design to the ICPAT (CPc) was negative.  
In this study, we consider the correlation if p <0.05.  
The highest correlation was negative in Clinical 
pathway 3 compliance with standard (ICPAT) with 
value of p= -0.784, while same value ‘-0.721’found for 
another two Clinical pathway designs. 
 Interestingly, despite the incompliance of the CP3 
to the ICPAT, less completeness was observed, which 
most likely could infer that the adherence to the 
standard in designing the clinical pathway might 
lead to not use it.  
A possible explanation for this could be that the 
design which is structured is time demanding or 
complex and would lead to losing interest in filling it.  
 
Table 5 Spearman correlation between Clinical Pathways 
completeness and Clinical Pathways compliance 
 
Correlation 
Clinical 
Pathways 
version 3 
Clinical 
Pathway
s version 
2 
Clinical 
Pathway
s version 
1 
Spea
rman
's rho 
Element of 
clinical 
pathway 
Correlation 
Coefficient 
-.784** -.721** -.721** 
Sig. (2-tailed) .001 .004 .004 
N 14 14 14 
Clinical 
Pathways 
version 3 
Correlation 
Coefficient 
1.000 .849 .849 
Sig. (2-tailed) . .000 .000 
N 14 14 14 
Clinical 
Pathways 
version 2 
Correlation 
Coefficient 
.849 1.000 1.000 
Sig. (2-tailed) .000 . . 
N 14 14 14 
Clinical 
Pathways 
version 1 
Correlation 
Coefficient 
.849 1.000 1.000 
Sig. (2-tailed) .000 . . 
N 14 14 14 
 
 
We tried to explain more the result that we found in 
the correlation analysis. We used the clinical 
pathway 1 as a benchmark and compared its 
component, and its arrangement and sequence with 
clinical pathway 2 and 3. We found that sequence of 
tasks was different in most of the components and 
sometimes is absent, such as in clinical pathway 1 
and the variance record was more detailed and 
framed in the clinical pathway 3. 
That might give insight to the reason in the high 
completeness of clinical pathway 1 regardless its 
incompatibility to standard as shown in Table 6. In 
general, there was a quite high compliance to the 
indicators mentioned in the ICPAT in designing the 
clinical pathway documents. Even though the three 
tested designs were almost similar in term of 
compliance to standard, it is important to mention 
that the only difference was the “documentation 
indicator” which presented only in clinical 
pathway3rd design. 
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Table 6 Individual Variation in the Clinical Pathway Tasks 
Arrangement and Sequence 
 
CP1 CP
2 
Arrangemen
t 
CP
3 
Arrangeme
nt 
Medical 
assessment 
√ 5, 6 & 1 √ 3 
Nursing x - √ 2 
Nutrition √ 8 √ 6 
Pharmacy 
(Medication
) 
√ 7 √ 4 
Rehabilitatio
n 
√ 9 √ 7 
Consultation √ 4 √ 8 
Education √ 11 √ 9 
Outcome √ 10 √ 8 
Variance √ 12 √ Additional 
sheet 
Nurse and 
Doctor in 
charge 
√ 14 √ 10 
cost √ 13 x - 
 
 
Most likely, that was the reason for the 
incompleteness of this document. By looking at the 
presence of variance framework in CP 3, we relate 
that to its incompleteness, assuming that the 
presence of more complex variance record was a 
time-consuming task that contributed to CP 3 
incompleteness. Furthermore, the reason for the 
difference between clinical pathway 1 and 2 in 
completeness could be explained if we look at the 
content of each one. The individual variation is 
shown in Table 6. 
 For example, in the process component certain 
tasks that should be provided to STEMI patient was 
absent or integrated with another section in the 
clinical pathway. Some were not given importance in 
the layout of the design, such as nursing tasks was 
absent from the Clinical Pathway 1 in the STEMI 
treatment process, and the variant record. 
We are considering the reality analysis is our 
strength in this study. To some extent, the finding of 
this study were limited by the small size for each type 
of documents especially the third clinical pathway or 
the time of implementation which might affected the 
results i.e. the three designs were implemented in 
different years. This finding, though are preliminary, 
suggests that design of clinical pathway could affect 
the users compliance to use it. Interestingly, following 
the standard in designing document is not enough to 
reassure the people will use it.  
However, these findings are rather disappointing, 
however, it is important to know that the results of this 
study do not explain how the time effect, the user 
type, is or other factors may affect the use of the 
documents. Not to omit the presence of some 
shortcoming in this study, such as the ‘source of 
data’. The data collection was done in the same 
hospital, while the same clinical pathway committee 
were the personnel who improved the versions of 
clinical pathway from one to three. That may explain 
the close correlation between the three designs 
results although it has been designed in different 
time. Therefore, to develop a full picture of the 
factors that affect the incompleteness, further data 
collection to clarify this limitation was done and will 
be presented in another publication. 
 
 
4.0  CONCLUSION 
 
The main goal of the current study was to describe 
and correlate the standard design with the 
completeness of the documents in the real setting. 
We found that the compliance has a quite significant 
relation to using clinical pathway in reality.  However, 
that relation has shown negative whenever the 
compliance to standard has been achieved. From 
the researcher’s opinion, these results could be 
explained by two ins and outs, the time of the trial 
and the complexity of the design. Further inferential 
analysis should be done to study the effect of other 
factors on the use of clinical pathway in hospitals 
and therefore patient care.   
In short, there is a reluctance to use certain CP. The 
result of this study is in agreement with what have 
been found in quality literature, as the standard is 
rigid may lead to low quality [9]. Improvement of 
care should consider the construct design factor and 
the user’s preferences. 
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